Chronic Necrotizing Aspergillosis: A New Risk with Teriflunomide in Multiple Sclerosis Patients? - Sorbonne Université Access content directly
Journal Articles REVUE NEUROLOGIQUE Year : 2022

Chronic Necrotizing Aspergillosis: A New Risk with Teriflunomide in Multiple Sclerosis Patients?

Domains

Human health and pathology

Gestionnaire HAL 3 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03793522

Submitted on : Saturday, October 1, 2022-10:29:20 AM

Last modification on : Friday, April 19, 2024-4:19:00 PM

No file

Dates and versions

hal-03793522 , version 1 (01-10-2022)

Identifiers

Cite

Valérie Pourcher, Jennifer Yeung, Françoise Le Pimpec-Barthes, Elisabeth Maillart, Laure Gibault, et al.. Chronic Necrotizing Aspergillosis: A New Risk with Teriflunomide in Multiple Sclerosis Patients?. REVUE NEUROLOGIQUE, 2022, 178 (3), pp.266--267. ⟨10.1016/j.neurol.2021.06.012⟩. ⟨hal-03793522⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

EPHE CORDELIERS IPLESP PSL SORBONNE-UNIVERSITE SU-MEDECINE SU-SCIENCES UP-SANTE
15 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More